TG Therapeutics prices $32.5m public offering
This article was originally published in Scrip
Executive Summary
New York-based TG Therapeutics has priced a public offering of 5.7 million shares of common stock at $6.15 per share in a bid to raise $32.5m to fund the development of its two clinical candidates.